BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 29136547)

  • 1. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese herbs as chemical resource library for drug discovery of anti-infective and anti-inflammatory.
    Ding W; Gu J; Cao L; Li N; Ding G; Wang Z; Chen L; Xu X; Xiao W
    J Ethnopharmacol; 2014 Aug; 155(1):589-98. PubMed ID: 24928828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology-based virtual screening of natural products from Clerodendrum species for identification of novel anti-cancer therapeutics.
    Gogoi B; Gogoi D; Silla Y; Kakoti BB; Bhau BS
    Mol Biosyst; 2017 Jan; 13(2):406-416. PubMed ID: 28070575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure.
    Chen R; Wan J; Song J; Qian Y; Liu Y; Gu S
    Pharm Biol; 2017 Dec; 55(1):503-509. PubMed ID: 27937122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel inhibitors of Keap1/Nrf2 by a promising method combining protein-protein interaction-oriented library and machine learning.
    Shimizu Y; Yonezawa T; Sakamoto J; Furuya T; Osawa M; Ikeda K
    Sci Rep; 2021 Apr; 11(1):7420. PubMed ID: 33795749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of in silico approaches to identify novel bioactive molecules from natural resources.
    Olğaç A; Orhan IE; Banoglu E
    Future Med Chem; 2017 Sep; 9(14):1665-1686. PubMed ID: 28841048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds.
    Ebrahim HY; El Sayed KA
    Mar Drugs; 2016 Mar; 14(3):. PubMed ID: 26978377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fr-PPIChem: An Academic Compound Library Dedicated to Protein-Protein Interactions.
    Bosc N; Muller C; Hoffer L; Lagorce D; Bourg S; Derviaux C; Gourdel ME; Rain JC; Miller TW; Villoutreix BO; Miteva MA; Bonnet P; Morelli X; Sperandio O; Roche P
    ACS Chem Biol; 2020 Jun; 15(6):1566-1574. PubMed ID: 32320205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.
    Si Y; Xu D; Bum-Erdene K; Ghozayel MK; Yang B; Clemons PA; Meroueh SO
    ChemMedChem; 2019 Jan; 14(1):119-131. PubMed ID: 30548204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
    Liu M; Quinn RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated discovery of FOXO1-DNA stabilizers from marine natural products to restore chemosensitivity to anti-EGFR-based therapy for metastatic lung cancer.
    Sun Y; Ai X; Hou J; Ye X; Liu R; Shen S; Li Z; Lu S
    Mol Biosyst; 2017 Jan; 13(2):330-337. PubMed ID: 27966721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining ligand- and structure-based in silico methods for the identification of natural product-based inhibitors of Akt1.
    Mahajan P; Wadhwa B; Barik MR; Malik F; Nargotra A
    Mol Divers; 2020 Feb; 24(1):45-60. PubMed ID: 30798436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of natural products as chemical library for drug discovery and network pharmacology.
    Gu J; Gui Y; Chen L; Yuan G; Lu HZ; Xu X
    PLoS One; 2013; 8(4):e62839. PubMed ID: 23638153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14-3-3 Protein-Protein Interactions.
    Andrei SA; de Vink P; Sijbesma E; Han L; Brunsveld L; Kato N; Ottmann C; Higuchi Y
    Angew Chem Int Ed Engl; 2018 Oct; 57(41):13470-13474. PubMed ID: 30025189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
    Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
    Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.